SCHEMBL7705845

SCHEMBL7705845

Nc1cc(-c2ccc(F)c(Cl)c2)cc2nc(-c3ccccn3)nn12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 3/20 0.49
GRM5 P41594 7/20 0.41
NPC1 O15118 4/20 0.40
L3MBTL1 Q9Y468 4/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
MAPT P10636 3/20 0.40
TP53 P04637 2/20 0.40
RAB9A P51151 2/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 2/20 0.39
PPP1CA P62136 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
MEN1 O00255 1/20 0.38
PKM P14618 1/20 0.38
TSHR P16473 1/20 0.38
KMT2A Q03164 1/20 0.38
ADORA1 P30542 2/20 0.37
F2 P00734 1/20 0.37
F12 P00748 1/20 0.37
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708907 0.90 ADORA2A (0.52) ADORA2AGRM5NPC1L3MBTL1SMN1; SMN2
SCHEMBL7705856 0.88 ADORA2A (0.54) ADORA2AGRM5NPC1L3MBTL1SMN1; SMN2
SCHEMBL7703127 0.85 ADORA2A (0.52) ADORA2AGRM5NPC1L3MBTL1SMN1; SMN2
SCHEMBL7703193 0.85 ADORA2A (0.46) ADORA2AGRM5NPC1SMN1; SMN2MAPT
SCHEMBL7427435 0.85 ADORA2A (0.54) ADORA2AGRM5NPC1L3MBTL1SMN1; SMN2
SCHEMBL7708837 0.83 GRM5 (0.52) ADORA2AGRM5NPC1L3MBTL1SMN1; SMN2
SCHEMBL7428533 0.82 ADORA2A (0.60) ADORA2ANPC1L3MBTL1SMN1; SMN2MAPT
SCHEMBL7426515 0.82 ADORA2A (0.51) ADORA2AGRM5NPC1L3MBTL1SMN1; SMN2
SCHEMBL7708776 0.82 ADORA2A (0.53) ADORA2AGRM5NPC1L3MBTL1SMN1; SMN2
SCHEMBL7708534 0.82 ADORA2A (0.53) ADORA2AGRM5NPC1L3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 US disclosed